Quince Therapeutics (QNCX) Other Working Capital Changes (2018 - 2026)

Quince Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at -$362000.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 201.69% year-over-year to -$362000.0 in Q2 2026; TTM through Jun 2026 was $908000.0, a 198.8% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 272.82% from the prior year.
• Other Working Capital Changes was -$362000.0 for Q2 2026 at Quince Therapeutics, down from $3.6 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $486000.0 in Q3 2025, with the low at -$4.8 million in Q4 2025.
• Average Other Working Capital Changes over 5 years is -$361466.7, with a median of $8000.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes sank 3264.29% in 2023, then jumped 2300.0% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$184000.0 in 2022, then tumbled by 972.83% to -$2.0 million in 2023, then surged by 84.09% to -$314000.0 in 2024, then plunged by 773.57% to -$2.7 million in 2025, then surged by 86.8% to -$362000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$362000.0 (Q2 2026), $3.6 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.